Goldman Sachs Upgrades Hospira To Neutral By: Benzinga via Benzinga February 06, 2015 at 07:42 AM EST Analysts at Goldman Sachs upgraded Hospira Inc. (NYSE: HSP) from Sell to Neutral. The price target for Hospira has been raised from ... Read More >> Related Stocks: Hospira